Cargando…

Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarker

Although serum galectin-1 antibodies (s-GAL-1-Abs) have been evaluated in a small number of patients with cancer, a large series of patients with different cancer types have not been reported. The current study evaluated 1,833 patients with esophageal cancer (n=172), gastric cancer (n=317), colorect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nanami, Tatsuki, Hoshino, Isamu, Shiratori, Fumiaki, Yajima, Satoshi, Oshima, Yoko, Suzuki, Takashi, Ito, Masaaki, Hiwasa, Takaki, Kuwajima, Akiko, Shimada, Hideaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278395/ https://www.ncbi.nlm.nih.gov/pubmed/34276998 http://dx.doi.org/10.3892/mco.2021.2341

Ejemplares similares

Diagnostic impact of high serum midkine level in patients with gastric cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?
por: Ito, Masaaki, et al.
Publicado: (2018)

The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
por: Ito, Masaaki, et al.
Publicado: (2023)

Preoperative Low Serum Calcium Levels Predict Poor Prognosis for Patients with Esophageal Cancer
por: Shiratori, Fumiaki, et al.
Publicado: (2021)

Is High Score of Preoperative Lactate Dehydrogenase to Albumin Ratio Predicting Poor Survivals in Esophageal Carcinoma Patients?
por: Shiratori, Fumiaki, et al.
Publicado: (2023)

Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric Cancer
por: Ito, Masaaki, et al.
Publicado: (2022)

High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
por: Ito, Masaaki, et al.
Publicado: (2021)

Possible predictive significance of serum RalA autoantibodies on relapse-free survival in patients with colorectal cancer
por: Ushigome, Mitsunori, et al.
Publicado: (2021)

Prognostic impact of p53 and/or NY‐ESO‐1 autoantibody induction in patients with gastroenterological cancers
por: Hoshino, Isamu, et al.
Publicado: (2020)

Panel of autoantibodies against multiple tumor‐associated antigens for detecting gastric cancer
por: Hoshino, Isamu, et al.
Publicado: (2017)

Randomized Phase II Study to Comparing Docetaxel/Nedaplatin versus Docetaxel for 5-Fluorouracil/Cisplatin Resistant Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2021)

Comparison between a new assay system, Elecsys(®) Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional study
por: Suzuki, Takashi, et al.
Publicado: (2022)

Multipanel assay of 17 tumor‐associated antibodies for serological detection of stage 0/I breast cancer
por: Sumazaki, Makoto, et al.
Publicado: (2021)

Inducing multiple antibodies to treat squamous cell esophageal carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020)

Does Preoperative Low HbA1c Predict Esophageal Cancer Outcomes?
por: Kochi, Ryosuke, et al.
Publicado: (2019)

A case of Barrett’s esophageal cancer with gastric mucosa-associated lymphoma
por: Shiratori, Fumiaki, et al.
Publicado: (2020)

Neck Dissection for Thoracic Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2012)

Anti‐FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer
por: Kobayashi, Sohei, et al.
Publicado: (2021)

Anti‐FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma
por: Kobayashi, Sohei, et al.
Publicado: (2019)

Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma
por: Shimada, Hideaki, et al.
Publicado: (2009)

Elevation of Autoantibody in Patients with Ischemic Stroke
por: YOSHIDA, Yoichi, et al.
Publicado: (2018)

Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors
por: Hontani, Koji, et al.
Publicado: (2017)

Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis
por: Hu, Liubing, et al.
Publicado: (2022)

Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi-institutional study
por: Okada, Rei, et al.
Publicado: (2022)

A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients
por: Sumazaki, Makoto, et al.
Publicado: (2020)

Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library
por: Kobayashi, Sohei, et al.
Publicado: (2018)

Analysis of patients with colorectal cancer shows a specific increase in serum anti-ING1 autoantibody levels
por: Arasawa, Takahiro, et al.
Publicado: (2023)

Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas
por: Adachi-Hayama, Masayo, et al.
Publicado: (2014)

The role of seven autoantibodies in lung cancer diagnosis
por: Luo, Bin, et al.
Publicado: (2021)

Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma
por: Kagaya, Akiko, et al.
Publicado: (2011)

Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion Research
por: Ishioka, Nobuki, et al.
Publicado: (2021)

Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients
por: Kobayashi, Sohei, et al.
Publicado: (2016)

Usefulness of serum miR-1246/miR-106b ratio in patients with esophageal squamous cell carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020)

Elevated levels of autoantibodies against EXD2 and PHAX in the sera of patients with chronic thromboembolic pulmonary hypertension
por: Naito, Akira, et al.
Publicado: (2019)

Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer
por: Mu, Yinyu, et al.
Publicado: (2020)

Galectins and Ovarian Cancer
por: Shimada, Chisa, et al.
Publicado: (2020)

Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
por: Li, Shu-Yang, et al.
Publicado: (2023)

Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies
por: Sato, Shinji, et al.
Publicado: (2016)

Application Value Analysis of Seven-Autoantibody Panel in the Lung Cancer Screening in Yunnan
por: Li, Wenrun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6v7pkr9um5udeuqih4jlk5gj3q